High-yield points
- Grade the veins:
- Borden I sinus only, II sinus plus cortical, III cortical only ;
- Cognard I, IIa/IIb/IIa+b, III (no ectasia), IV (ectasia), V (spinal) .
- Cortical venous drainage = high risk. Persistent CVR carries 10.4% annual mortality and 15% annual events .
- Zipfel: symptomatic CVD about 7.5% annual hemorrhage vs about 1.5% for asymptomatic .
- Cognard V (perimedullary drainage) presents with myelopathy in half .
- Treat the reflux: disconnecting the cortical venous drainage is the goal .
Landmark papers
- Borden classification (Borden et al., J Neurosurg 1995): a three-type classification of cranial and spinal dural fistulas by venous drainage .
- Cognard classification (Cognard et al., Radiology 1995): a five-type classification with subtypes, correlated with clinical course .
- Zipfel modifier (Zipfel et al., Neurosurg Focus 2009): annual hemorrhage rate was 7.4–7.6% for symptomatic vs 1.4–1.5% for asymptomatic cortical venous drainage .
Use this to classify an intracranial dural arteriovenous fistula (dAVF) from its angiogram. Both standard scales grade the venous drainage, because that is what sets the risk:
- Borden has three types ;
- Cognard has five, with subtypes .
Cortical venous drainage (CVD) is the dividing line between benign and aggressive fistulas . The Zipfel modifier then splits CVD by presentation, symptomatic or asymptomatic .
In children, start with the pediatric shunt type: infantile-type fistulas and dural sinus malformations behave differently (see Dural AV Fistulas in Children).
Pick one option in each group that applies. The sinus-flow question matters only for sinus drainage; the ectasia and parenchymal reflux questions matter only for direct cortical drainage.
Open the interactive calculator in the book →
The scales
- Borden (1995) :
- Type I: drains directly into a dural sinus or meningeal vein.
- Type II: drains into a sinus or meningeal vein, plus retrograde drainage into subarachnoid (cortical) veins.
- Type III: drains into subarachnoid veins only, with no sinus or meningeal venous drainage.
- In every type, the arterial supply comes from meningeal arteries. The scheme unifies cranial and spinal dural fistulas.
- Cognard (1995) :
- Type I: in the main sinus, antegrade flow.
- Type II: in the main sinus, with reflux:
- IIa, into the sinus;
- IIb, into cortical veins;
- IIa+b, both.
- Type III: direct cortical venous drainage without venous ectasia.
- Type IV: direct cortical venous drainage with venous ectasia.
- Type V: spinal (perimedullary) venous drainage.
- How they map:
- Borden I = Cognard I and IIa.
- Borden II = Cognard IIb and IIa+b.
- Borden III = Cognard III, IV and V.
- CVD is present in Borden II and III, and Cognard IIb, IIa+b, III, IV and V .
Risk by type
- Cognard's clinical correlation (presentation and course in the 1995 series) :
- Type I: benign course.
- Type II:
- sinus reflux caused intracranial hypertension in 20%;
- cortical reflux caused hemorrhage in 10%.
- Type III: hemorrhage in 40%.
- Type IV: hemorrhage in 65%.
- Type V: progressive myelopathy in 50%.
- Persistent cortical venous reflux (20 patients who declined or had partial treatment, followed a mean 4.3 years) :
- annual mortality 10.4%;
- annual hemorrhage 8.1% and nonhemorrhagic neurological deficit 6.9%, a combined 15.0% per year.
- The Zipfel modifier :
- Symptomatic CVD (sCVD): presentation with intracranial hemorrhage or nonhemorrhagic neurological deficit.
- Asymptomatic CVD (aCVD): incidental, pulsatile tinnitus or orbital/ophthalmic symptoms.
- Annual hemorrhage rate: 7.4–7.6% for sCVD vs 1.4–1.5% for aCVD .
- Source series (28 patients with Borden 2–3) :
- annual event rates (hemorrhage or deficit) were 1.4% vs 19.0%;
- aCVD had significantly better event-free survival.
- Parenchymal venous reflux refines direct cortical drainage further . In 128 Cognard III–IV fistulas:
- 61% showed angiographic reflux into parenchymal veins;
- this carried a 7-fold risk of aggressive presentation;
- untreated annual hemorrhage or deficit was 31.6% with PVR vs 2.4% without.
Treatment implications
- No CVD (Borden I; Cognard I and IIa): low risk.
- Treatment is mainly for intolerable symptoms (tinnitus, ocular signs) .
- Cognard IIa can still cause intracranial hypertension , which matters in a child with papilledema or a growing head.
- CVD present: the goal is disconnection of the cortical venous reflux :
- endovascular (transarterial or transvenous);
- surgical disconnection;
- radiosurgery for selected lesions .
- Asymptomatic CVD has a gentler course but is not risk-free (1.4–1.5% annual hemorrhage) . Most still favor treatment when it can be done safely.
In children
- Pediatric dAVFs are rare and differ from adult ones. Classify by Lasjaunias type first (see Dural AV Fistulas in Children):
- dural sinus malformation;
- infantile-type;
- adult-type.
- Adult-type fistulas in older children can be graded with Borden and Cognard as in adults.
- Infantile-type fistulas and dural sinus malformations are judged mainly by:
- flow;
- heart failure;
- venous drainage and sinus thrombosis;
- development.
- The risk numbers above come from mostly adult series .
Related topics
- Dural Arteriovenous Fistulas in Children: pediatric shunt types and management.
- Vein of Galen Malformation: another high-flow pediatric shunt lesion.
- Cerebral Sinovenous Thrombosis: sinus thrombosis and venous hypertension.
- Brain AVMs in Children: parenchymal arteriovenous shunts.
- Spinal AVM and AV Fistula Classifier (Kim–Spetzler, Type I–IV and Bicêtre): the spinal counterpart.
References
- Borden JA, Wu JK, Shucart WA. A proposed classification for spinal and cranial dural arteriovenous fistulous malformations and implications for treatment. J Neurosurg 1995;82(2):166–179. doi:10.3171/jns.1995.82.2.0166. PMID 7815143. verified
- Cognard C, Gobin YP, Pierot L, et al. Cerebral dural arteriovenous fistulas: clinical and angiographic correlation with a revised classification of venous drainage. Radiology 1995;194(3):671–680. doi:10.1148/radiology.194.3.7862961. PMID 7862961. verified
- Zipfel GJ, Shah MN, Refai D, et al. Cranial dural arteriovenous fistulas: modification of angiographic classification scales based on new natural history data. Neurosurg Focus 2009;26(5):E14. doi:10.3171/2009.2.FOCUS0928. PMID 19408992. verified
- Strom RG, Botros JA, Refai D, et al. Cranial dural arteriovenous fistulae: asymptomatic cortical venous drainage portends less aggressive clinical course. Neurosurgery 2009;64(2):241–247; discussion 247–248. doi:10.1227/01.NEU.0000338066.30665.B2. PMID 19190453. verified
- van Dijk JM, terBrugge KG, Willinsky RA, et al. Clinical course of cranial dural arteriovenous fistulas with long-term persistent cortical venous reflux. Stroke 2002;33(5):1233–1236. doi:10.1161/01.str.0000014772.02908.44. PMID 11988596. verified
- Ma L, Lang MJ, Gross BA. Cortical drainage directly into a sinus versus drainage with angiographic parenchymal venous reflux: improved stratification of "high-risk" dural arteriovenous fistulas. Neurosurgery 2026;98(3):669–677. doi:10.1227/neu.0000000000003664. PMID 40742222. verified
- Gross BA. Cerebral dural arteriovenous fistulas. Stroke Vasc Interv Neurol 2022;2(4):e000532. doi:10.1161/SVIN.122.000532. PMID 41584768. verified
Verification (2026-11-17):
- Each reference's authors, title, journal, year, volume, pages, DOI and PMID were checked on PubMed.
- Type definitions and every number were checked against the PubMed abstracts.
Caveats:
- The Borden–Cognard mapping and the list of CVD-positive types follow reference 3.
- Calling Cognard I–IIa "low risk" and reserving treatment for symptoms reflects reference 7's review, not a trial.
- "Most still favor treatment" for asymptomatic CVD is the authors' reading of current practice.
- The pediatric guidance is this text's synthesis with the Dural AV Fistulas in Children topic. No pediatric validation of these scales was found.
- Reference 5's rates come from a small selected group (20 patients) and reference 4's from 28 patients.